Document:

EX-10.1

 Exhibit 10.1 

Execution Version 

STOCKHOLDERS AGREEMENT OF 

RENT THE RUNWAY, INC. 
 THIS
STOCKHOLDERS AGREEMENT, dated as of October 29, 2021 (as it may be amended, amended and restated or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), is entered into by and among
(i) Rent the Runway, Inc., a Delaware corporation (the “Corporation”), (ii) Jennifer Y. Hyman, the Trust under Article Second UA dtd 9/19/2012 (the “2012 Trust”), the BS 2021 Family Trust (the “Family
Trust”), the JYH 2021 Children’s Trust (the “Children’s Trust”, and, together with Jennifer Y. Hyman, the 2012 Trust and the Family Trust, the “Founder”), (iii) Bain Capital Venture Fund 2009,
L.P. (“BCV Fund 2009”), BCIP Venture Associates (“BCIP Venture”) and BCIP Venture Associates-B (“BCIP Venture-B”, and,
together with BCV Fund 2009 and BCIP Venture, the “Bain Capital Ventures Entities”), and (iv) Highland Capital Partners VIII Limited Partnership (“Highland Capital 8”), Highland Capital Partners VIII-B Limited Partnership (“Highland Capital 8-B”) and Highland Capital Partners VIII-C Limited Partnership
(“Highland Capital 8-C” and, together with Highland Capital 8 and Highland Capital 8-B, the “Highland Entities”, and together with the
Bain Capital Ventures Entities and the Founder, the “Stockholders”). Certain terms used in this Agreement are defined in Section 6. 

RECITALS 
 WHEREAS, the Corporation
is contemplating an offering and sale of shares of Class A common stock, par value $0.001 per share, of the Corporation (the “Class A Common Stock”) in an underwritten initial public offering (the
“IPO”); 
 WHEREAS, in connection with the consummation of the IPO, it is anticipated that all of the outstanding series of the
Corporation’s convertible, redeemable preferred stock will be converted into Common Stock (as defined in the Corporation’s Eleventh Amended and Restated Certificate of Incorporation) (the “Automatic Conversion”); 

WHEREAS, in connection with the consummation of the IPO and following the Automatic Conversion, the Corporation will amend and restate its certificate
of incorporation to reclassify the shares of Common Stock (as defined in the Eleventh Amended and Restated Certificate of Incorporation) into Class A Common Stock; 

WHEREAS, in connection with the consummation of the IPO, it is anticipated that the Founder, the Corporation and certain other stockholders of the
Corporation will enter into a series of related transactions pursuant to which the Founder will exchange all shares of the Founder’s Class A Common Stock for shares of the Corporation’s Class B Common Stock, par value $0.001 per
share (the “Class B Common Stock” and, together with the Class A Common Stock, the “Common Stock”); 

WHEREAS, the parties hereto desire to set forth their agreement with respect to the matters set forth herein in connection with their respective
investments in the Corporation. 
 NOW, THEREFORE, in consideration of the covenants and agreements contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Corporation and the Stockholders agree as follows: 

 Agreement 

Section 1. Election of the Board of Directors. 

(a) Subject to this Section 1(a), the Bain Capital Ventures Entities shall be entitled to designate for nomination by
the Board one (1) Director from time to time (any Director designated by the Bain Capital Ventures Entities, a “BCV Director”). The Bain Capital Ventures Entities shall not be entitled to designate any BCV Director in
accordance with this Section 1(a) if at any time the Bain Capital Ventures Entities beneficially own, directly or indirectly, in the aggregate less than five percent (5%) of all issued and outstanding shares of Class A
Common Stock. The Directors shall be divided into three classes of directors, each of whose members shall serve for staggered three-year terms in accordance with the Charter. 

(b) Subject to this Section 1(b), the Highland Entities shall be entitled to designate for nomination by the Board
one (1) Director from time to time (any Director designated by the Highland Entities, a “Highland Director”). The Highland Entities shall not be entitled to designate any Highland Director in accordance with this
Section 1(b) if at any time the Highland Entities beneficially own, directly or indirectly, in the aggregate less than five percent (5%) of all issued and outstanding shares of Class A Common Stock. The Directors shall
be divided into three classes of directors, each of whose members shall serve for staggered three-year terms in accordance with the Charter. 

(c) Subject to this Section 1(c), the Founder shall be entitled to designate for nomination by the Board up to the
number of Directors specified in this Section 1(c) (any Director designated by the Founder, a “Founder Director”). The Founder Directors shall be apportioned among the three (3) classes of Directors as nearly equal in
number as possible. The right of the Founder to designate the Founders Directors as set forth in this Section 1(c) shall be subject to the following: (i) if at any time the Founder beneficially owns, directly or indirectly, in the
aggregate shares of Class A Common Stock and Class B Common Stock representing fifteen percent (15%) or more of the total voting power of all issued and outstanding shares of Class A Common Stock and Class B Common Stock, the
Founder shall be entitled to designate for nomination nine (9) Founder Directors, and (ii) if at any time the Founder beneficially owns, directly or indirectly, in the aggregate shares of Class A Common Stock and Class B Common
Stock representing less than fifteen percent (15%) but at least five percent (5%) or more of the total voting power of all issued and outstanding shares of Class A Common Stock and Class B Common Stock, the Founder shall only be entitled
to designate for nomination five (5) Founder Directors. The Founder shall not be entitled to designate any Founder Directors in accordance with this Section 1(c) if at any time the Founder beneficially owns, directly
or indirectly, in the aggregate shares of Class A Common Stock and Class B Common Stock representing less than five percent (5%) of the total voting power of all issued and outstanding shares of Class A Common Stock and Class B
Common Stock. Notwithstanding anything to the contrary set forth in this Section 1(c), so long as Jennifer Y. Hyman serves as the Chief Executive Officer of the Corporation, Ms. Hyman shall be nominated by the
Board as a Director and, if so elected, in that capacity she shall serve as one of the Founder Directors. 
 (d) Subject to
Section 1(a), Section 1(b) and Section 1(c), each of the Bain Capital Ventures Entities, Highland Entities and Founder hereby agree, severally and not jointly, with the
Corporation (and only with the Corporation), and the Corporation agrees with each of the Bain Capital Ventures Entities, Highland Entities and Founder, to vote, or cause to be voted, all outstanding shares of Class A Common Stock and/or
Class B Common Stock, as applicable, held by the Bain Capital Ventures Entities, Highland Entities and Founder, respectively at any annual or special meeting of stockholders of the Corporation at which Directors of the Corporation are to be
elected or removed, and to take all Necessary Action to cause the election or removal of each of the BCV Director, the Highland Director and the Founder Directors as a Director, as provided herein and to implement and enforce the provisions set
forth in Section 3. 

  
 2 

 Section 2. Vacancies and Replacements. 

(a) If the number of Directors that the Bain Capital Ventures Entities, Highland Entities or Founder have the right to designate to the Board
is decreased pursuant to Section 1(a), Section 1(b) or Section 1(c) (each such occurrence, a “Decrease in Designation Rights”), then: unless a majority of
Directors (with the affected party’s Board designees abstaining) agree in writing that a Director or Directors shall not resign as a result of a Decrease in Designation Rights, each of the Bain Capital Ventures Entities, Highland Entities or
Founder, as applicable, agrees with the Corporation (and only with the Corporation) that it shall take all Necessary Action to cause each of (x) the BCV Director that the Bain Capital Ventures Entities cease to have the right to designate for
nomination as a BCV Director or (y) the Highland Director that the Highland Entities cease to have the right to designate for nomination as a Highland Director or (z) the appropriate number of Founder Directors that the Founder ceases to
have the right to designate for nomination as the Founder Directors, respectively, to tender his, her or their resignation(s) from the Board within thirty (30) days from the date that the Bain Capital Ventures Entities, Highland Entities and/or
Founder, as applicable, incurs a Decrease in Designation Rights, provided that this Section 2(a) shall not apply to Ms. Hyman as long as she serves as the Chief Executive Officer of the Corporation. 

(b) Other than with respect to a Decrease in Designation Rights, each of the Bain Capital Ventures Entities, Highland Entities and Founder
shall have the sole right to request that one or more of their respective designated Directors, as applicable, tender their resignations as Directors of the Board (each, a “Removal Right”), in each case, with or without cause at any
time, by sending a written notice to such Director and the Corporation’s Secretary stating the name of the Director or Directors whose resignation from the Board is requested. 

(c) Except with respect to a Decrease in Designation Rights subject to Section 2(a), each of the Bain Capital
Ventures Entities, Highland Entities and Founder, as applicable, shall have the exclusive right to designate a replacement Director for nomination or election by the Board to fill vacancies created as a result of not designating their respective
Directors initially or by death, disability, retirement, resignation, removal (with or without cause) of their respective Directors, or otherwise by designating a successor for nomination or election by the Board to fill the vacancy of their
respective Directors created thereby on the terms and subject to the conditions of Section 1. 
 Section 3. Initial
Directors and Corporate Governance. 
 (a) Initial Directors. The initial BCV Director designated for nomination pursuant to
Section 1(a) shall initially be Scott Friend (designated for nomination as a Class II Director). The initial Highland Director designated for nomination pursuant to Section 1(b) shall initially be Dan Nova (designated for nomination
as a Class II Director). The initial Founders Directors designated for nomination pursuant to Section 1(c) shall initially be Jennifer Y. Hyman (designated for nomination as a Class III Director) and Tim Bixby, Jennifer Fleiss and
Carley Roney designated for nomination as Class I Directors; Melanie Harris and Mike Ross designated for nomination as Class II Directors; and Beth Kaplan, Gwyneth Paltrow and Dan Rosenzweig designated for nomination as Class III
Directors. 
 (b) Chief Executive Officer. Immediately following the consummation of the IPO, the Chief Executive Officer of the
Corporation shall be Jennifer Y. Hyman. Ms. Hyman shall not be removed or terminated as Chief Executive Officer without “Cause” (as such term is defined in Ms. Hyman’s employment agreement with the Corporation in effect as
of the date hereof) without the approval of (i) a majority of the Directors comprising the Board and (ii) a majority of the Founder Directors, in each case with Ms. Hyman recusing herself from such vote. 

  
 3 

 Section 4. Covenants of the Corporation. 

(a) The Board and the Corporation agree with each of the Stockholders, individually and not jointly, to use their reasonable best efforts to
take all Necessary Action (subject to the Board’s fiduciary duties) to (i) cause the Board to be comprised of at least eleven (11) Directors or such other number of Directors as the Board may determine, subject to the terms of this
Agreement, the Charter or the Bylaws of the Corporation; (ii) cause the individuals designated in accordance with Section 1 to be included in the slate of nominees to be elected to the Board at the next annual or
special meeting of stockholders of the Corporation at which Directors are to be elected, in accordance with the Bylaws, Charter and General Corporation Law of the State of Delaware and at each annual meeting of stockholders of the Corporation
thereafter at which such Director’s term expires; and (iii) cause the individuals designated in accordance with Section 2(c) to fill the applicable vacancies on the Board, in accordance with the Bylaws, Charter,
Securities Laws, General Corporation Law of the State of Delaware and The Nasdaq Stock Exchange rules. 
 (b) The Bain Capital Ventures
Entities, Highland Entities and Founder each agrees with the Corporation (and only with the Corporation) that it shall comply with the requirements of the Charter and Bylaws when designating and nominating individuals as Directors, in each case, to
the extent such requirements are applicable to Directors generally. Notwithstanding anything to the contrary set forth herein, in the event that the Board determines, within sixty (60) days after compliance with the first sentence of this
Section 4(b), in good faith, after consultation with outside legal counsel, that its nomination, appointment or election of a particular Director designated in accordance with Section 1 or
Section 2, as applicable, would constitute a breach of its fiduciary duties to the Corporation’s stockholders or does not otherwise comply with any requirements of the Charter or Bylaws and Securities Laws, then the
Board shall inform the Bain Capital Ventures Entities, Highland Entities and/or Founder, as applicable, of such determination in writing and explain in reasonable detail the basis for such determination and shall, to the fullest extent permitted by
law, nominate, appoint or elect another individual designated for nomination, election or appointment to the Board by the Bain Capital Ventures Entities, Highland Entities and/or Founder, as applicable (subject in each case to this
Section 4(b)). The Board and the Corporation shall, to the fullest extent permitted by law, take all Necessary Action (subject to the Board’s fiduciary duties) required by this Section 4 with respect to the nomination, appointment or
election of such substitute designees to the Board. 
 Section 5. Termination. 

This Agreement shall terminate upon the earliest to occur of any one of the following events: 

(a) each of (i) the Bain Capital Ventures Entities, (ii) the Highland Entities and (iii) the Founder ceasing to own any shares
of Class A Common Stock or Class B Common Stock; 
 (b) each of (i) the Bain Capital Ventures Entities, (ii) Highland
Entities and (iii) the Founder ceasing to have any Director designation rights under Section 1; and 
 (c) the
unanimous written consent of the parties hereto. 
 For the avoidance of doubt, the rights and obligations (i) of the Bain Capital
Ventures Entities under this Agreement shall terminate upon the earliest to occur of (a) the Bain Capital Ventures Entities ceasing to own any shares of Class A Common Stock or (b) a BCV Director ceasing to serve as a Director,
(ii) of the Highland Entities under this Agreement shall terminate upon the earliest to occur of (a) Highland Entities ceasing to own any shares of Class A Common Stock or (b) a Highland Director ceasing to serve as a Director
and (iii) of the Founder under this Agreement shall terminate upon the earliest to occur of (a) the Founder ceasing to own any shares of Class A Common Stock or Class B Common Stock or (b) any

  
 4 

 
Founder Director ceasing to serve as a Director. For the avoidance of doubt, in the event a Stockholder’s rights and obligations under this Agreement terminate as a result of such
Stockholder ceasing to have any designee of such Stockholder serve as a Director, such Stockholder may not thereafter seek to reinstate its rights by designating a nominee for election to the Board pursuant to Section 1 hereof. Notwithstanding
the foregoing, nothing in this Agreement shall modify, limit or otherwise affect, in any way, any and all rights to indemnification, exculpation and/or contribution owed to any of the parties hereto, to the extent arising out of or relating to
events occurring prior to the date of termination of this Agreement or the date the rights and obligations of such party under this Agreement terminates in accordance with this Section 5. 

Section 6. Definitions. 
 As used in
this Agreement, any term that it is not defined herein, shall have the following meanings: 
 “Board” means the board of
directors of the Corporation. 
 “Bylaws” means the amended and restated bylaws of the Corporation, dated as of the date
hereof, as the same may be further amended, restated, amended and restated or otherwise modified from time to time. 

“Charter” means the amended and restated certificate of incorporation of the Corporation, effective as of the date hereof, as
the same may be further amended, restated, amended and restated or otherwise modified from time to time. 
 “Director”
means a member of the Board. 
 “Necessary Action” means, with respect to a specified result, all commercially reasonable
actions required to cause such result that are within the power of a specified Person, including (i) voting or providing a written consent or proxy with respect to the equity securities owned by the Person obligated to undertake the necessary
action, (ii) voting in favor of the adoption of stockholders’ resolutions and amendments to the organizational documents of the Corporation, (iii) executing agreements and instruments, and (iv) making, or causing to be made, with
governmental, administrative or regulatory authorities, all filings, registrations or similar actions that are required to achieve such result. 

“Person” means any individual, corporation, limited liability company, partnership, trust, joint stock company, business
trust, unincorporated association, joint venture, governmental authority or other entity or organization, including a government or any subdivision or agency thereof. 

“Securities Laws” means the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, and the
rules promulgated thereunder. 
 Unless the context of this Agreement otherwise requires, (i) words of any gender include each other
gender; (ii) words using the singular or plural number also include the plural or singular number, respectively; (iii) the terms “hereof,” “herein,” “hereby” and derivative or similar words refer to this
entire Agreement; (iv) the terms “Article” or “Section” refer to the specified Article or Section of this Agreement; (v) the word “including” shall mean “including, without limitation”; (vi) each
defined term has its defined meaning throughout this Agreement, whether the definition of such term appears before or after such term is used; and (vii) the word “or” shall be disjunctive but not exclusive. References to agreements
and other documents shall be deemed to include all subsequent amendments and other modifications thereto. References to statutes shall include all regulations promulgated thereunder and references to statutes or regulations shall be construed as
including all statutory and regulatory provisions consolidating, amending or replacing the statute or regulation. 

  
 5 

 Section 7. Choice of Law and Venue; Waiver of Right to Jury Trial. 

(a) THIS AGREEMENT SHALL BE GOVERNED BY, CONSTRUED, APPLIED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF DELAWARE. EACH OF
THE PARTIES HERETO ACKNOWLEDGES AND AGREES THAT IN THE EVENT OF ANY BREACH OF THIS AGREEMENT, THE NON-BREACHING PARTY WOULD BE IRREPARABLY HARMED AND COULD NOT BE MADE WHOLE BY MONETARY DAMAGES, AND THAT, IN
ADDITION TO ANY OTHER REMEDY TO WHICH THEY MAY BE ENTITLED AT LAW OR IN EQUITY, THE PARTIES SHALL BE ENTITLED TO SUCH EQUITABLE OR INJUNCTIVE RELIEF AS MAY BE APPROPRIATE. THE CORPORATION HEREBY AGREES WITH EACH STOCKHOLDER, SEVERALLY AND NOT
JOINTLY, THAT IT WILL ENFORCE THE PROVISIONS OF THIS AGREEMENT AGAINST ANY PARTY IN BREACH. THE CHOICE OF FORUM SET FORTH IN THIS SECTION SHALL NOT BE DEEMED TO PRECLUDE THE ENFORCEMENT OF ANY JUDGMENT OF A DELAWARE FEDERAL OR STATE COURT, OR THE
TAKING OF ANY ACTION UNDER THIS AGREEMENT TO ENFORCE SUCH A JUDGMENT, IN ANY OTHER APPROPRIATE JURISDICTION. 
 (b) IN THE EVENT ANY PARTY TO
THIS AGREEMENT COMMENCES ANY LITIGATION, PROCEEDING OR OTHER LEGAL ACTION IN CONNECTION WITH OR RELATING TO THIS AGREEMENT, ANY RELATED AGREEMENT OR ANY MATTERS DESCRIBED OR CONTEMPLATED HEREIN OR THEREIN, THE PARTIES TO THIS AGREEMENT HEREBY
(1) AGREE UNDER ALL CIRCUMSTANCES ABSOLUTELY AND IRREVOCABLY TO SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE COURT OF CHANCERY OF THE STATE OF DELAWARE, OR IF (AND ONLY IF) SUCH COURT FINDS IT LACKS SUBJECT MATTER JURISDICTION, THE SUPERIOR
COURT OF THE STATE OF DELAWARE (COMPLEX COMMERCIAL DIVISION), OR IF UNDER APPLICABLE LAW, SUBJECT MATTER JURISDICTION OVER THE MATTER THAT IS THE SUBJECT OF THE ACTION OR PROCEEDING IS VESTED EXCLUSIVELY IN THE FEDERAL COURTS OF THE UNITED STATES OF
AMERICA, THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE, AND APPELLATE COURTS FROM ANY THEREOF, WITH RESPECT TO ALL ACTIONS AND PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY;
(2) AGREE THAT IN THE EVENT OF ANY SUCH LITIGATION, PROCEEDING OR ACTION, SUCH PARTIES WILL CONSENT AND SUBMIT TO THE PERSONAL JURISDICTION OF ANY SUCH COURT DESCRIBED IN CLAUSE (1) OF THIS SECTION 7(b); (3) AGREE TO WAIVE TO THE
FULL EXTENT PERMITTED BY LAW ANY OBJECTION THAT THEY MAY NOW OR HEREAFTER HAVE TO THE VENUE OF ANY SUCH LITIGATION, PROCEEDING OR ACTION IN ANY SUCH COURT OR THAT ANY SUCH LITIGATION, PROCEEDING OR ACTION WAS BROUGHT IN ANY INCONVENIENT FORUM;
(4) AGREE TO WAIVE ANY RIGHTS TO A JURY TRIAL TO RESOLVE ANY DISPUTES OR CLAIMS RELATING TO THIS AGREEMENT; (5) AGREE TO SERVICE OF PROCESS IN ANY LEGAL PROCEEDING BY MAILING OF COPIES THEREOF TO SUCH PARTY AT ITS ADDRESS SET FORTH HEREIN
FOR COMMUNICATIONS TO SUCH PARTY; (6) AGREE THAT ANY SERVICE MADE AS PROVIDED HEREIN SHALL BE EFFECTIVE AND BINDING SERVICE IN EVERY RESPECT; AND (7) AGREE THAT NOTHING HEREIN SHALL AFFECT THE RIGHTS OF ANY PARTY TO EFFECT SERVICE OF
PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. 

  
 6 

 Section 8. Notices. 

Any notice, request, claim, demand, document and other communication hereunder to any party shall be effective upon receipt (or refusal of
receipt) and shall be in writing and delivered personally or sent by facsimile, or by electronic mail, or first-class mail, or by Federal Express or other similar courier or other similar means of communication, as follows: 

 

	 	(a)	 If to Founder, addressed as follows: 

398 State Street 
 Brooklyn, New
York 11217 
 Attention: Jennifer Y. Hyman 

E-mail: *******@******* 

with a copy (which copy shall not constitute notice) to: 

Withers Bergman LLP 
 505 Sansome
Street, 2nd Floor 
 San Francisco, California 94111 

Attention: Doug Mandell 
 E-mail: *******@******* 
  

	 	(b)	 If to Bain Capital Ventures Entities, addressed as follows: 

Bain Capital Ventures 
 200
Clarendon Street 
 Boston, Massachusetts 02116 

Attention: David Hutchins 
 E-mail: *******@******* 
  

	 	(c)	 If to Highland Entities, addressed as follows: 

Highland Capital Partners 
 One
Broadway, 16th Floor 
 Cambridge, Massachusetts 02142 

Attention: Jessica Healey 
 E-mail: *******@******* 
 with a copy (which shall not constitute notice) to: 

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP 

One Marina Park Drive, Suite 900 

Boston, Massachusetts 02210 

Attention: Jay K. Hachigian and Keith J. Scherer 

Email: *******@******* 
  

	 	(d)	 If to the Corporation, addressed as follows: 

Rent the Runway, Inc. 
 10 Jay
Street 
 Brooklyn, New York 11201 

Telephone: (212) 524-6860 

Attention: Cara Schembri, General Counsel 

E-mail: *******@******* 

  
 7 

 with a copy (which copy shall not constitute notice) to: 

Latham & Watkins LLP 

1271 Avenue of the Americas 

New York, New York 10020 

Attention: Marc Jaffe and Emily Taylor 

Facsimile: (212) 906-1623 

E-mail: *******@******* 

or, in each case, to such other address or email address as such party may designate in writing to each party by written notice given in the manner specified
herein. All such communications shall be deemed to have been given, delivered or made when so delivered by hand or sent by facsimile (with confirmed transmission), on the next business day if sent by overnight courier service (with confirmed
delivery) or when received if sent by first class mail, or in the case of notice by electronic mail, when the relevant email enters the recipient’s server. 

Section 9. Assignment. 
 Except as
otherwise provided herein, all of the terms and provisions of this Agreement shall be binding upon, shall inure to the benefit of and shall be enforceable by the respective successors and permitted assigns of the parties hereto. This Agreement may
not be assigned (by operation of law or otherwise) without the express prior written consent of the other parties hereto, and any attempted assignment, without such consents, will be null and void. 

Section 10. Amendment and Modification; Waiver of Compliance. 

This Agreement may not be amended, modified, altered or supplemented except by means of a written instrument executed on behalf of each of the
Corporation, Bain Capital Ventures Entities, Highland Entities and Founder. Except as otherwise provided in this Agreement, any failure of any of the parties to comply with any obligation, covenant, agreement or condition herein may be waived by the
party or parties entitled to the benefits thereof only by a written instrument signed by the party or parties granting such waiver, but such waiver or failure to insist upon strict compliance with such obligation, covenant, agreement or condition
shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure. 
 Section 11. Waiver. 

No failure on the part of any party hereto to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of
any party hereto in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver thereof; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further
exercise thereof or of any other power, right, privilege or remedy. 
 Section 12. Severability. 

If any provision of this Agreement, or the application of such provision to any Person or circumstance or in any jurisdiction, shall be held
to be invalid or unenforceable to any extent, (i) the remainder of this Agreement shall not be affected thereby, and each other provision hereof shall be valid and enforceable to the fullest extent permitted by law, (ii) as to such Person
or circumstance or in such jurisdiction such provision shall be reformed to be valid and enforceable to the fullest extent permitted by law and (iii) the application of such provision to other Persons or circumstances or in other jurisdictions
shall not be affected thereby. 

  
 8 

 Section 13. Counterparts. 

This Agreement may be executed in any number of counterparts and signatures may be delivered by facsimile, each of which may be executed by
less than all parties, each of which shall be enforceable against the parties actually executing such counterparts, and all of which together shall constitute one instrument. 

Section 14. Further Assurances. 
 At
any time or from time to time after the date hereof, the parties hereto agree to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as any
other party may reasonably request in order to evidence or effectuate the provisions of this Agreement and to otherwise carry out the intent of the parties hereunder. 

Section 15. Titles and Subtitles. 

The descriptive headings of this Agreement are inserted for convenience only and do not constitute a part of this Agreement. 

Section 16. Representations and Warranties. 

(a) Each of the Bain Capital Ventures Entities, Highland Entities, Founder and each Person who becomes a party to this Agreement after the date
hereof, severally and not jointly and solely with respect to itself, represents and warrants to the Corporation as of the time such party becomes a party to this Agreement that (a) if applicable, it is duly authorized to execute, deliver and
perform this Agreement; (b) this Agreement has been duly executed by such party and is a valid and binding agreement of such party, enforceable against such party in accordance with its terms; and (c) the execution, delivery and
performance by such party of this Agreement does not violate or conflict with or result in a breach of or constitute (or with notice or lapse of time or both constitute) a default under any agreement to which such party is a party or, if applicable,
the organizational documents of such party. 
 (b) The Corporation represents and warrants to each other party hereto that (a) the
Corporation is duly authorized to execute, deliver and perform this Agreement; (b) this Agreement has been duly authorized, executed and delivered by the Corporation and is a valid and binding agreement of the Corporation, enforceable against
the Corporation in accordance with its terms; and (c) the execution, delivery and performance by the Corporation of this Agreement does not violate or conflict with or result in a breach by the Corporation of or constitute (or with notice or
lapse of time or both constitute) a default by the Corporation under the Charter or Bylaws, any existing applicable law, rule, regulation, judgment, order, or decree of any governmental authority exercising any statutory or regulatory authority of
any of the foregoing, domestic or foreign, having jurisdiction over the Corporation or any of its Subsidiaries or any of their respective properties or assets, or any agreement or instrument to which the Corporation or any of its Subsidiaries is a
party or by which the Corporation or any of its Subsidiaries or any of their respective properties or assets may be bound. 

  
 9 

 Section 17. No Strict Construction. 

This Agreement shall be deemed to be collectively prepared by the parties hereto, and no ambiguity herein shall be construed for or against
any party based upon the identity of the author of this Agreement or any provision hereof. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

  
 10 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed on the day
and year first above written. 
  

			
	RENT THE RUNWAY, INC.
	
	By: /s/ Jennifer Y.
Hyman                                        
    
	Name: Jennifer Y. Hyman
	Title:   Chief Executive Officer
	
	JENNIFER Y. HYMAN
	
	By: /s/ Jennifer Y.
Hyman                                        
    
	Name: Jennifer Y. Hyman
	
	TRUST UNDER ARTICLE SECOND U/A DTD 9/19/2012
	
	By: /s/ Linda
Hyman                                        
            
	Name: Linda Hyman
	Title:   Trustee
	
	BS 2021 FAMILY TRUST
	
	By: /s/ Justin
Finnegan                                        
        
	Name: Justin Finnegan
	Title:   Trustee
	
	JYH 2021 CHILDREN’S TRUST
	
	By: /s/ Justin
Finnegan                                        
        
	Name: Justin Finnegan
	Title:   Trustee

 [Signature Page to Stockholders Agreement] 

 
	
	BAIN CAPITAL VENTURE FUND 2009, L.P.
	
	 By: Bain Capital Venture Partners, L.P.,
 its
General Partner

	 By: Bain Capital Venture Investors, LLC,
 its
General Partner

	
	 By: /s/ Scott Friend

	Name: Scott Friend
	Title: Managing Director
	
	BCIP VENTURE ASSOCIATES
	
	 By: Boylston Coinvestors, LLC,
 its Managing
Partner

	
	 By: /s/ Scott Friend

	Name: Scott Friend
	Title: Authorized Signatory
	
	BCIP VENTURE ASSOCIATES-B
	
	 By: Boylston Coinvestors, LLC,
 its Managing
Partner

	
	 By: /s/ Scott Friend

	Name: Scott Friend
	Title: Authorized Signatory

 [Signature Page to Stockholders Agreement] 

 

 
	
	HIGHLAND CAPITAL PARTNERS VIII LIMITED PARTNERSHIP
	
	 By: Highland Management Partners VIII Limited

Partnership, its general partner

	 By: Highland Management Partners VIII Limited,

its general partner

	
	By: /s/ Dan
Nova                                         
               
	Name: Dan Nova
	Title:   Authorized Signatory
	
	HIGHLAND CAPITAL PARTNERS VIII-B LIMITED PARTNERSHIP
	
	By: Highland Management Partners VIII Limited Partnership, its general partner
	By: Highland Management Partners VIII Limited, its general partner
	
	By: /s/ Dan
Nova                                         
               
	Name: Dan Nova
	Title:   Authorized Signatory
	
	HIGHLAND CAPITAL PARTNERS VIII-C LIMITED PARTNERSHIP
	
	By: Highland Management Partners VIII Limited Partnership, its general partner
	By: Highland Management Partners VIII Limited, its general partner
	
	By: /s/ Dan
Nova                                         
               
	Name: Dan Nova
	Title:   Authorized Signatory

 [Signature Page to Stockholders Agreement]Exhibit 10.1

October 26, 2021

 

Matthew David, M.D.

 

		Re:	Interim Chief Executive Officer Letter Agreement

 

Dear Matt:

 

As we have discussed, you will serve as the interim Chief Executive
Officer of Cormedix Inc. (“Interim CEO”), effective as of October 4, 2021, until such time as Cormedix appoints a new Chief
Executive Officer. You understand and agree that you will also continue to serve as CorMedix’s EVP and Chief Financial Officer during
this period, subject to the terms of your Employment Agreement dated as of May 11, 2020 with CorMedix (“Employment Agreement”).
This letter agreement sets forth certain understandings with respect to your compensation and the Employment Agreement in connection with
this Interim CEO position.

 

		1.	Base Salary. Section 4(a) of the Employment Agreement is amended to read as follows:

 

(a) Base Salary.
As of October 4, 2021, and for so long as Executive continues to serve as CorMedix’s interim Chief Executive Officer (“Interim
CEO”), the Company shall pay Executive an annual base salary of four hundred twenty-five thousand dollars ($425,000), less
applicable withholdings and deductions. If Executive continues to serve as Interim CEO six months after October 4, 2021, the Board, or
its Compensation Committee, will review such base salary to determine whether an increase is appropriate at that time.

 

After Executive ceases to serve as Interim CEO, and continues
to serve as Chief Financial Officer, during the Initial Term, the Company shall pay Executive an annual base salary of three hundred seventy-five
thousand dollars ($375,000), less applicable withholdings and deductions. The Board, or its Compensation Committee, will review such base
salary to determine whether an increase is appropriate in 2022 as part of the 2022 compensation review cycle and benchmarking review.

 

The applicable base salary as described above and as it may
be increased from time to time as provided herein is referred to as the “Base Salary.” Upon the expiration of
the Initial Term, the Board, or its Compensation Committee, shall review the Base Salary to determine whether an increase in the amount
thereof is warranted in its sole discretion. The Base Salary will not be decreased unless (i) all officers and/or members of the Company’s
executive management team experience an equal or greater percentage reduction in annual base salary and/or total compensation; and
(ii) Executive’s Base Salary reduction is no greater than twenty-five percent (25%) of the applicable Base Salary.

 

     

     

    

 

		2.	Annual Bonus. Section 4(b) of the Employment Agreement is amended to add a sentence to the end to read as follows:

 

Notwithstanding the foregoing, (i) the target amount for
the annual bonus with respect to the period during which Executive serves as Interim CEO shall be 60% instead of 30% and (ii) if and at
such time as Executive ceases to serve as Interim CEO and continues to serve as Chief Financial Officer, such target bonus shall be 40%
of the Base Salary (and for the year in which he is no longer Interim CEO, the bonus will be determined pro rata).

 

		3.	Compensation Upon Termination. Section 9(c)(ii) of the Employment Agreement is amended to read as follows:

 

(ii) (A) If Executive’s employment terminates under
this Section 9(c) while Executive serves as Interim CEO, payment to Executive of an amount equal to twelve (12) months of his Base Salary,
which shall be paid over a period of twelve (12) months following the termination date, or (B) if Executive’s employment terminates
under this Section 9(c) after Executive ceases to serve as Interim CEO, payment to Executive of an amount equal to nine (9) months of
his Base Salary, which shall be paid over a period of nine (9) months following the termination date.

 

		4.	Stock Option Grant. In connection with your serving as Interim CEO, the Board of Directors of CorMedix will grant you a stock
option with respect to 125,000 shares of Cormedix stock within 15 days after the date of this letter agreement. The exercise price of
the option will be the closing price of the CorMedix stock on the New York Stock Exchange on the date of grant, and the option will vest
over four years in four equal annual installments beginning on the date of grant, subject to your continued employment, consistent with
the terms of the standard form of option agreement used by the Company.

 

		5.	Good Reason. Under Section 8(d) of the Employment Agreement, a “material reduction by the Company of [your] duties, responsibilities,
or authority” without your consent can trigger “Good Reason” for termination. You agree that your services as Interim
CEO are intended to be temporary, and when you cease to serve as Interim CEO, such change will not, in and of itself, constitute Good
Reason under Section 8(d) of the Employment Agreement.

 

Please sign below to confirm your agreement with the terms of this
letter.

 

Sincerely,

 

	CORMEDIX INC.	 
	 	 	 
	By:	/s/ Myron Kaplan	 
	Name: 	Myron Kaplan	 
	Title:	Chair of the Board of Directors of CorMedix, Inc.	 

 

    2

     

    

 

ACCEPTED, ACKNOWLEDGED AND
AGREED:

 

	By:	/s/ Matthew David	 
	Name: 	Matthew David, M.D.	 
	Dated:	 October 26, 2021	 

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]